ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,779Medicare Part D Prescriptions Filled, Including Refills

Rank: 124 out of 1278

$442K Total Retail Price of All Prescriptions

Rank: 165 out of 1278

543 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 543 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,233 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 528 497 1 1
SIMVASTATIN 431 417 2 3
AMLODIPINE BESYLATE 403 382 3 5
LEVOTHYROXINE SODIUM 365 350 4 2
METFORMIN HCL 331 300 5 4
PRAVASTATIN SODIUM 298 263 6 14
HYDROCHLOROTHIAZIDE 292 287 7 8
OMEPRAZOLE 285 281 8 6
ATORVASTATIN CALCIUM 270 258 9 15
METOPROLOL TARTRATE 205 191 10 9
FUROSEMIDE 172 167 11 10
PREDNISONE 165 144 12 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 134 13 30
POTASSIUM CHLORIDE 137 128 14 21
GABAPENTIN 131 108 15 12
LOVASTATIN 120 99 16 13
LOSARTAN POTASSIUM 116 109 17 19
ATENOLOL 109 93 18 11
GEMFIBROZIL 108 105 19 54
TAMSULOSIN HCL 90 90 20 32
DIOVAN 89 84 21 44
ZOLPIDEM TARTRATE 86 84 22 16
KLOR-CON 10 70 65 23 91
CITALOPRAM HBR 70 70 23 22
AMOXICILLIN 67 63 25 124
LOSARTAN-HYDROCHLOROTHIAZIDE 67 59 25 75
PAROXETINE HCL 65 65 27 56
RANITIDINE HCL 65 62 27 20
SERTRALINE HCL 64 61 29 28
WARFARIN SODIUM 63 62 30 17
FLUOXETINE HCL 61 56 31 41
BENAZEPRIL HCL 57 39 32 81
METOPROLOL SUCCINATE 56 55 33 23
AMITRIPTYLINE HCL 56 56 R 33 55
TERAZOSIN HCL 56 56 33 59
GLYBURIDE 55 43 R 36 40
HYDROCODONE-ACETAMINOPHEN 52 51 S3 37 7
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 18, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.